Did you know?

You can download information on Zafgen's management team and MetAP2 inhibition?

Media Library

Clinical Trials

We collaborate with the world’s leading obesity and metabolic disease experts from academic institutions and contract research organizations to apply the best thinking to advance our understanding of the molecular mechanism of our program.

Expected Pipeline







Zafgen announced on July 19, 2016 the strategic decision to suspend development of beloranib.